Product Description: PLX7904 is a potent and selective BRAF inhibitor, with IC50 of appr 5 nM against BRAFV600E in mutant RAS expressing cells.
Applications: Cancer-Kinase/protease
Formula: C24H22F2N6O3S
References: [1]Zhang C, et al. RAF inhibitors that evade paradoxical MAPK pathway activation. Nature. 2015 Oct 22;526(7574):583-586./[2]Basile KJ, et al. Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors. Pigment Cell Melanoma Res. 2014 May;27(3):479-84/[3]Le K, et al. Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells. Pigment Cell Melanoma Res. 2013 Jul;26(4):509-17
CAS Number: 1393465-84-3
Molecular Weight: 512.53
Compound Purity: 98.94
Research Area: Cancer
Solubility: DMSO : ≥ 30 mg/mL
Target: Raf